Previous Article | Next Article 
Molecular and Cellular Biology, December 2000, p. 8731-8739, Vol. 20, No. 23
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Cell-Type-Specific Regulation of the Retinoic Acid
Receptor Mediated by the Orphan Nuclear Receptor TLX
Mime
Kobayashi,1,2,*
Ruth T.
Yu,2
Kunio
Yasuda,1 and
Kazuhiko
Umesono2
Graduate School of Biological Sciences, Nara
Institute of Science and Technology, Ikoma, Nara
630-0101,1 and Department of Genetics
and Molecular Biology, Institute for Virus Research, Kyoto
University, Kyoto 606-8507,2 Japan
Received 18 February 2000/Returned for modification 1 May
2000/Accepted 18 September 2000
 |
ABSTRACT |
Malformations in the eye can be caused by either an excess or
deficiency of retinoids. An early target gene of the retinoid metabolite, retinoic acid (RA), is that encoding one of its own receptors, the retinoic acid receptor
(RAR
). To better
understand the mechanisms underlying this autologous regulation, we
characterized the chick RAR
2 promoter. The region surrounding the
transcription start site of the avian RAR
2 promoter is over 90%
conserved with the corresponding region in mammals and confers strong
RA-dependent transactivation in primary cultured embryonic retina
cells. This response is selective for RAR but not retinoid X
receptor-specific agonists, demonstrating a principal role for RAR(s)
in retina cells. Retina cells exhibit a far higher sensitivity to RA
than do fibroblasts or osteoblasts, a property we found likely due to
expression of the orphan nuclear receptor TLX. Ectopic expression of
TLX in fibroblasts resulted in increased sensitivity to RA induction,
an effect that is conserved between chick and mammals. We have
identified a cis element, the silencing element relieved by
TLX (SET), within the RAR
2 promoter region which confers TLX- and
RA-dependent transactivation. These results indicate an important role
for TLX in autologous regulation of the RAR
gene in the eye.
 |
INTRODUCTION |
The vitamin A derivative retinoic
acid (RA) has been suggested to play important roles in vertebrate
embryonic development and cell differentiation. Vitamin A deficiency
and/or excessive doses of RA are known to result in a
spectrum of distinct malformations during organogenesis and pattern
formation (reviewed in references 8, 19, and 49).
Two classes of receptors, RA receptors (RARs) and retinoid X
receptors (RXRs), which belong to a large family of nuclear
hormone receptors, mediate RA signaling. These receptors are capable of
binding specific target DNA sequences in the regulatory regions of
responsive genes, termed RA response elements (RAREs), to activate or
repress transcription (5, 29).
Among vitamin A metabolites, all-trans-RA (at-RA) has
been shown to bind the RARs, whereas a stereoisomer of at-RA,
9-cis-RA, acts as a high-affinity bipotential ligand for
both RARs and RXRs. A RAR and RXR preferentially form a heterodimer to
bind RAREs consisting of a direct repeat of canonical AGGTCA
sequences separated by two or five nucleotides (28).
Three subtypes of the gene for RAR,
,
, and
, have been
identified in chick (33), mouse (58), and human
(22) and are expressed in distinct spatial and temporal
patterns during embryogenesis. In the chick embryo, RAR
has been
shown to be prominently expressed in the developing central nervous
system and RAR
expression is mainly restricted to the skin, whereas RAR
expression is rather ubiquitous (32, 44, 48, 50). Several isoforms exist for each subtype. In mammals, the genes for all three subtypes can be transcribed from at least two
different promoters, resulting in variation at the amino termini
between isoforms. For RAR
, four distinct mRNAs result from use of
alternative promoters (
1 and
2) and splicing variations
(59). In chick, distinct forms of RAR
mRNAs display
individual patterns of expression during embryogenesis (45,
48).
One of the parameters modulating the differential expression of RARs
and RXRs is RA itself. The human and mouse RAR
2 promoters have a
well-conserved RARE (the so-called
RARE) just upstream of the TATA
box. As a result, the RAR
2 promoters are highly inducible by RA and
are considered to be one of the earliest targets of RA action (11,
51).
In transgenic mice with the RAR
2 promoter fused to the
Escherichia coli
-galactosidase (
-gal) gene,
-gal
activity was present in the pigmented retina (31, 41).
-gal staining was also observed in the eye of a RARE-
-gal
transgenic embryo. Staining was increased upon maternal treatment with
RA, suggesting that in vivo, some of the morphogenetic effects of RA
could be mediated through localized transcriptional activity controlled
by the various RARs (2, 43).
In chick embryos, RAR
transcripts can be upregulated by exogenously
added RA. Implantation of RA-soaked beads in limb buds causes rapid
(within 4 h) accumulation of RAR
2 mRNA (39, 54). This induction was also observed by Northern analysis using mRNA isolated from facial primordia (45). Together these data
strongly suggest that the mechanisms underlying the autologous
regulation of RAR
gene expression are well conserved between mammals
and avians.
TLX is an orphan nuclear receptor originally identified on the basis of
its similarity to RXR; it is structurally and functionally (biochemically) homologous to the Drosophila terminal-gap
gene tailless. Expression of TLX is restricted to the fore-
and midbrain, neuroepithelium, retina, and nasal epithelium (18,
36, 57). We and others have shown that the function of TLX is
necessary for the proper formation of specific eye and brain
structures, but the precise molecular mechanisms of its action are
still being unraveled (17, 35, 56).
Here we show that the RAR
2 promoters and TLX proteins are highly
conserved during evolution and that TLX can modulate the autoregulation
of the RAR
2 promoter.
 |
MATERIALS AND METHODS |
Isolation of chick RAR
promoter.
A chick 3-day embryonic
cDNA library was screened with a fragment of mouse RXR
as the probe
(57). Multiple cDNA clones were found to encode the
chick RAR
, including clones corresponding to mRNAs utilizing
both
1 and
2 promoters. Sequence information from the
RAR
2 cDNA clone containing the longest 5' noncoding region was
used to design primers for PCR. The primer sequences used for genomic
PCR analyses were as follows: NMO1
(5'-GCTCTTGCAGGGCTGCTGGGAGTTT-3'), NMO2
(5'-AATCTCTCTAGAACCAGTCCCGTTCCTCAG-3'), NMO8
(5'-CCCTCAGCCATGAATAGATCCTTC-3'), and NMO9
(5'-CCTGCCTCTCTGGCTGTCTGCTTT-3'). First, for the NMO9-NMO2 primer combination, PCR amplification was carried out for 33 cycles (30 s at 94°C, 1 min at 50°C, 2 min at 72°C) with 50 ng of chick genomic DNA, 200 ng of each primer, and 2.5 U of Taq DNA
polymerase (Life Technologies). A second round of amplification was
carried out for 25 cycles, using 1/50 of the first PCR mixture as the template with the NMO1-NMO8 primer combination. Products from the
second PCR were separated on agarose gel and purified, and a 220-bp
fragment was ligated into the TA cloning vector pMOSBlue (Amersham). The DNA sequence was determined with an AutoCycle sequencing kit on an A.L.F. II DNA sequencer (Pharmacia). Sequences of
at least two clones from each of three independent PCR products were determined.
Cloning of human TLX cDNA.
The National Center for
Biotechnology Information expressed sequence tag database was searched
for sequences related to the chick TLX, using the program BLASTN
(1). Two expressed sequence tags with similarity to chick
TLX, those with the GenBank accession numbers R18964 and R43976, were
identified from a single human infant brain cDNA clone, am156j01.
The plasmid encompassing am156j01 was used to design oligonucleotide
probe NMO63 (5'-GACAACTCCGGTTAGATGC-3'). The full-length
human TLX cDNA clone in the mammalian expression vector was
selected using the GENETRAPPER cDNA Positive Selection System
(Life Technologies) from among 4 × 1011 clones of a
human fetal brain cDNA pCMV-SPORT2 library (Life Technologies).
Cell culture and transfection assay.
CV-1 and MC3T3-E1 cells
were maintained in Dulbecco's modified Eagle's medium (DMEM) and
-MEM medium (Life Technologies), respectively, supplemented with
10% fetal bovine serum (FBS). Retina cells were isolated from day-4.5
chick embryos according to the method described previously
(40). Cells were washed with phosphate-buffered
saline-EDTA, treated with 0.125% trypsin, and plated on 24-well
dishes (Costar). Retina cells were kept in 10% FBS-DMEM for 4 days.
Then 2 h prior to transfection, medium was replaced with 10%
charcoal-resin double-treated FBS-DMEM. Transfections were performed
by the calcium phosphate precipitation method as previously described
(53). Cells were transfected for 6 h in 24-well dishes
with a total of 750 ng of DNA/well adjusted by pGEM4 plasmid together
with 250 ng (or 150 ng for the thymidine kinase [tk]-driven reporter)
of reporter plasmid, 350 ng of reference plasmid (pCMX-
GAL), and 50 ng of receptor plasmid. After washing out of DNA precipitates, cells
were incubated with added ligand for 36 h. Cell extracts were
subsequently prepared and assayed for luciferase and
-gal
activities. All data points were determined in triplicate and
normalized for transfection efficiency with
-gal as an internal
control. at-RA (Nacalai, Kyoto, Japan) and 9-cis-RA (Wako
Pure Chemical, Osaka, Japan) stock solutions were prepared in 20%
dimethyl sulfoxide-80% ethanol. Synthetic retinoids LG69 and TTNPB,
kindly provided by R. Heyman, were solubilized in dimethyl sulfoxide
and added at the indicated concentrations.
Serum stripping.
FBS (Life Technologies) was equilibrated
twice with equal volumes of n-heptane for 2 h at room
temperature. After the second separation, the recovered serum was
stirred twice with 50 g of resin (AG 1-X8, analytical grade,
200/400 mesh; Bio-Rad)/liter and 20 g of charcoal/liter. After
centrifugation to remove particulates, the serum was passed through a
0.22-µm-pore-size filter for sterilization.
Reverse transcription-PCR analyses.
Total RNA was isolated
from primary cultured chick retina cells with ISOGEN (Nippon Gene,
Toyama, Japan), and cDNA template was prepared with a RNA PCR kit
(Takara Shuzo, Kyoto, Japan) according to the manufacturer's
instructions. Using 200 ng of each primer, PCR amplification was
performed for 30 cycles (30 s at 94°C, 60 s at 68°C, 90 s
at 72°C) with 2.5 U of Ex-Taq DNA polymerase (Takara Shuzo). The sequences of the 5' primers for RAR
transcripts are as
follows: NMO46 (5'-ACTGAATGGTGGTCTGAGACACGGACTAAG-3') for
1 and NMO3 (5'-CTGAGGAACGGGACTGGTTCTAGAGAGATT-3') for
2. NMO21 (5'-CTTGGAACAAGTTCCTCAGAACTGGTGCTC-3') was used
as the common 3' RAR
primer. The NMO53
(5'-GATGGTCAGGTCATCACCATTGG-3') and NMO54
(5'-CATCGTACTCCTGCTTGCTGATCC-3') primer set was used for
-actin. The identity of each RAR
2 promoter-derived PCR product was confirmed by sequencing of at least four independent clones.
Plasmid constructions.
The expression vectors pCMX-hRXR
(55), pCMX-cTLX, pCMX-mTLX (57), pCMX-hRAR
,
and pCMX-
GAL and reporter plasmids tk-LUC and m
RARE-tk-LUC
(53), which were used in the transfection assay, have been
previously described. The coding region of human COUP-TFII/ARP-1
(24) was cloned into the EcoRI site of the pCMX vector (53) to create the pCMX-hCOUP-TFII expression vector. The c
RARE-tk-LUC, SET-tk-LUC, SET-m
RARE-tk-LUC,
m
RARE-SET-tk-LUC, SETm1-m
RARE-tk-LUC, and
SETm2-m
RARE-tk-LUC reporter plasmids were prepared by
inserting the synthetic oligonucleotides c
RARE (agctTGGGTTCACAGAAAGTTCACTCGagct), SET
(agctTGGGTCATTTGAAGGTTAGCagct), SETm1
(agctTGAACCATTTGAAGGTTAGCagct), SETm2
(agctTGGGTCATTTGAAAACTAGCagct), and m
RARE
(agctTAAGGGTTCACCGAAAGTTCACTCGCATagct) into the
HindIII site of a tk-LUC basal luciferase reporter
or m
RARE-tk-LUC reporter. The mouse RAR
2-
2.2k-LUC
promoter reporter plasmid was made by inserting a 2.2-kb fragment
(including the transcription start site of mouse RAR
2) into the
SalI/XhoI site to replace the tk promoter of the
tk-LUC reporter plasmid. For the chick RAR
2-
119-LUC, first, the
PCR-amplified fragment with NMO2 and NMO7
(5'-AAGCTCTGTGAGAATCCTGGGAG-3'), which encodes the
119 to
+68 region of the chick RAR
2 promoter, was ligated into the TA
cloning vector pMOSBlue (Amersham). The HindIII/BamHI fragment was excised for
ligation into the HindIII/BglII site to
replace the tk promoter of the tk-LUC reporter. For the chick
RAR
2-
85-LUC and the mouse RAR
2-
66-LUC, first, the PCR fragment-amplified with KMO45
(5'-GTACGTCGACTGGGTCATTTGAAGGTTAGCAG-3') and NMO2 or with
NMO5 (5'-GGTGGATCCAGCAGCCCGGGAAGGGTTCACCGAA-3') and
NMO6 (5'-GTACTCGAGGCACGGGAACTCTGGTCCCCCCCTT-3') was
excised with BamHI and SalI or XhoI.
The fragment was ligated into the SalI/BglII or
BamHI/XhoI site, respectively, to replace the tk promoter of the tk-LUC reporter. Sequences of the PCR-amplified region
were confirmed by standard methods.
Gel retardation assays.
Proteins were synthesized by an in
vitro transcription-translation system using rabbit reticulocyte
lysate (Promega) with plasmid pCMX-hRAR
, pCMX-hRXR
, pCMX-cTLX, or
pCMX-hCOUP-TFII. For binding, 4 µl of lysate was incubated
first in 10 mM Tris-HCl (pH 8.0), 80 mM KCl, 1 mM dithiothreitol, 0.1%
NP-40, 1 µg of poly(dI-dC), and 7.5% glycerol on ice for 20 min.
Excess unlabeled competitor oligonucleotides, when included, were added
during this preincubation period. Then 0.2 to 0.6 pmol of
32P-labeled oligonucleotide (3 × 105 cpm,
prepared by filling in with Klenow polymerase in the presence of
[
-32P]dCTP) probe was added to the reaction, followed
by incubation on ice for 30 min. The protein-DNA complexes were
resolved on a 5% polyacrylamide gel in 0.5× Tris-borate-EDTA
buffer. Gels were subsequently dried and subjected to autoradiography.
The same oligonucleotides described in plasmid constructions were used for gel retardation assays for SET, m
RARE, and SET-m
RARE. The Krüppel oligonucleotide was described previously
(57). The sequence of the nonspecific competitor is agctACAAGGTTCACGAGGTTCACGTCagct.
Nucleotide sequence accession numbers.
The sequences
reported in this paper have been deposited in the GenBank
database (accession no. AF220160, AF220161, AF220162, and
AF220163 for the chick RAR
2 promoter region and RAR
4',
RAR
4M, and RAR
4M' cDNA and AF220532 for human TLX cDNA.
 |
RESULTS |
Induction of RAR
expression in chick retina cells.
The
expression of RAR
s in chick embryonic retina cells was
examined by reverse transcription-PCR. Three distinct bands
were observed by agarose gel analysis (Fig.
1). Subcloning and subsequent DNA
sequencing of the PCR products revealed the presence of five RAR
isoforms; in addition to the previously reported
2 and
4 (38, 48), three were novel (Fig. 1). These isoforms are
apparently generated by alternative splicing and differ only in their
amino termini (Fig. 1). The chick RAR
4M (corresponding to mouse
RAR
4) isoform lacks an apparent acceptor sequence (AG) at nucleotide positions 617 and 618, suggesting the presence of an intron between nucleotides 618 and 619; an intron is present at the analogous position
in mouse RAR
(37). In cultured retina cells, the
expression of all RAR
2 isoforms is induced within 12 h of
addition of at-RA (Fig. 1). In contrast, the RAR
1 isoform appears
not to be affected by exogenous at-RA, indicating a specific role for
the RAR
2 promoter in retina cells (Fig. 1).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 1.
Induction of RAR 2 isoforms by RA in chick retina
cells. RNAs were reverse transcribed and amplified with chick RAR 2-,
1-, or -actin-specific primers. Three major bands were resolved
by 1.2% agarose gel in Tris-borate-EDTA buffer for RAR 2 isoforms
with apparent estimated sizes of 514, 288 to 291, and 155 to 158 bp.
The expression of RAR 2 isoforms is induced by 1 µM at-RA within
12 h in chick retina cells. No induction was observed 36 h
after medium change in the absence of exogenous at-RA. Note that the
expression of RAR 1 or -actin transcripts is not affected by
at-RA. Donor and acceptor sites for splicing are indicated in the
schematic representation of chick RAR isoforms (see Fig. 2 for
details). The nomenclature of RAR isoforms is based on correlation
to mouse and human RAR isoforms.
|
|
Determination of chick RAR
2 promoter sequence.
To compare
the mammalian and avian RAR
2 promoters, we isolated the chick
RAR
2 promoter region by genomic PCR. To accomplish this, 5' primers
were designed based upon the well-conserved human and/or mouse
sequences, while 3' primers were designed based on chick-specific
sequence from within the cDNA. Over 90% sequence identity was
observed among human, mouse, and chick genes in the 150-bp region
surrounding the transcription start site. The high conservation in
sequence also allowed prediction of the putative transcription start
site for the chick gene (11). We confirmed the presence of a
cyclic AMP RE, AP-1 binding site (TRE), RARE (
RARE), RNA polymerase
initiator site (INR), and TATA box (12) that are
conserved in mouse and human. Some short upstream open reading frames
(uORFs) which have been reported to regulate the translational level of
mouse RAR
2 were also found (Fig.
2) (42).

View larger version (116K):
[in this window]
[in a new window]
|
FIG. 2.
Nucleotide sequence and predicted amino acid sequence of
chick RAR . PCR primers used are indicated by arrows. The putative
transcription start site is designated +1. The cAMP RE (CRE), AP-1
binding site (TRE), RARE, TATA box, and RNA polymerase initiator
site (INR) sequences are indicated by boxes. An asterisk (*)
indicates the 5' end of the cDNA confirmed by cDNA library
screening. Splicing donor and acceptor sites are indicated by "d"
and "a", respectively. The boxed CTG indicates the non-AUG
initiation codon proposed for the mRAR 4 transcript
(37). The large arrow indicates the common region for all
RAR transcripts. The regions of short uORFs (uORF2 to -5) reported
for mouse RAR 2 (42) are underlined, and regions highly
conserved between mammals and avians are indicated by shaded boxes.
COUP-TF-RE (26) and SET sequences are indicated by double
and bold underlines, respectively.
|
|
Induction of RAR
2 promoter by at-RA is cell type specific.
As an initial step to characterize the function of the chicken RAR
2
promoter, we generated a luciferase reporter construct and confirmed
the ability of this region to direct RAR
2 transcription by
transient transfection in primary cultured chick embryonic retina
cells. Promoter activity could be induced by at-RA concentrations as
low as 0.1 µM (Fig. 3A). Activation by
9-cis-RA or a RAR-specific agonist (TTNPB) but not by
a RXR-specific agonist (LG69) was also observed. These results suggest
that the induction of RAR
2 expression is mediated primarily by RAR,
not RXR.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 3.
(A) RAR 2 promoter activity is induced by RAR agonists
but not by RXR-specific agonists. cRAR 2 promoter-driven luciferase
reporter plasmids (cRAR 2- 119-LUC) were transfected into primary
cultured chick retina cells. Final concentrations of retinoids are
indicated. (B) Induction of cRAR 2 promoter activity by at-RA is cell
type specific. cRAR 2 promoter-driven luciferase reporter plasmids
were transfected as described for Fig. 3A. at-RA was added to the
indicated final concentrations. Promoter activity is induced by at-RA
in all cell types, but the magnitude of induction differs.
|
|
Using this promoter construct, we examined the at-RA sensitivity of the
RAR
2 promoter in the monkey fibroblast cell line CV-1 and mouse
osteoblast cell line MC3T3-E1. Although promoter activity can also be
induced by at-RA in these cell lines, the level of induction is much
lower than that observed in the retina (Fig. 3B). These results,
consistent with other reports, indicate that there is cell
type-specific modulation of promoter activity and/or at-RA sensitivity
(10, 15, 26, 46).
Orphan receptor TLX potentiates at-RA induction of
RAR
2 promoter.
To investigate whether the above cell type
specificity is a result of the amount of RARs and/or RXRs expressed in
the cells, we tested the effect of overexpression of RARs or RXRs in
CV-1 cells. RAR
or RXR
only weakly potentiated at-RA induction of the RAR
2 promoter (Fig. 4A). RAR
,
RAR
, RXR
, RXR
, or combinations of RARs and RXRs were also
unable to significantly potentiate at-RA induction (data not shown). We
examined the effect of various orphan nuclear receptors and found that
TLX, which is expressed in retina, fore- and midbrain, and nasal
epithelium, potentiated at-RA response in CV-1 cells (Fig. 4A). This
effect was observed using chick, mouse, and human TLX constructs on
both chick and mouse RAR
2 promoter reporter constructs, indicating
that conservation of TLX-mediated at-RA signaling has occurred through
evolution (Fig. 4B to D). These results, along with the fact that
primary chick retina cells but not CV-1 or MC3T3-E1 cells (R. T. Yu, unpublished results) express high endogenous levels of TLX,
suggested the involvement of TLX in activation of the RAR
2 promoter
in retina cells.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 4.
TLX induces RA response to RAR 2 promoter activity in
CV-1 cells. (A) cRAR 2 promoter-driven luciferase reporter plasmids
were transfected as described for Fig. 3B with receptor plasmids. TLX
enhances at-RA induced promoter activity better than does RAR or RXR.
(B) Highly conserved structure of TLX proteins. Differences in amino
acids compared to those for human TLX are indicated in parentheses. (C)
The sensitizing effect of TLX is conserved during evolution. cRAR 2
promoter-driven luciferase reporter plasmids were transfected as
described for Fig. 4A. Enhancement of at-RA-induced promoter activity
is seen with all TLX constructs. (D) Identification of TLX-responsive
element on RAR 2 promoter region. Numbering corresponds to nucleotide
positions of the chick RAR 2 promoter sequence given for Fig. 2.
Sequential deletion constructs were examined for at-RA-dependent
transactivation with or without the presence of TLX. Chick TLX and
mouse sequence (for I and IV) or chick sequence (for II and III) was
used. Chick, mouse, and human RAR 2 promoter regions are aligned.
Dashes indicate homology with chick sequence.
|
|
Identification of a TLX-responsive element.
To investigate the
mechanism by which TLX modulates RA activation of the RAR
2 promoter,
we made a series of deletion constructs. In chick retina cells, these
constructs were equally induced by at-RA, thus posing difficulty for
identification of the TLX-responsive element using this system. CV-1
cells, on the other hand, lack endogenous TLX and thus served as a good
system for this analysis. Transient transfection of the above deletion
constructs revealed that fragments as short as
85 relative to the
transcription start site were sufficient and that the region between
85 and
66 was necessary to observe the TLX effect on at-RA response
(Fig. 4D). Examination of this region revealed the presence of a
putative RARE. Based on its function as described below, this element
is referred to as the silencing element relieved by TLX (SET) and is
conserved between mammalian and avian RAR
2 promoters (Fig. 4D and
5A) (10, 11, 47). To test the
at-RA and TLX responsiveness of SET, we subcloned each element into a
luciferase reporter driven by a tk minimal promoter. Transient
transfection analysis revealed that SET does not function as a RARE in
chick retina cells that express a high endogenous level of TLX (Fig.
5B). Consistent with the transfection results, gel retardation
assays revealed that RAR-RXR heterodimers cannot bind to SET
(Fig. 5C). TLX binds to neither SET nor
RARE (Fig. 5D) and does not
appear to affect the binding activity of RAR-RXR to a composite
RARE-SET (Fig. 5E). Likewise, COUP-TFII, another orphan
nuclear receptor shown to be important for the at-RA dependent
activation of the RAR
2 promoter (26), did not
affect the binding of RAR-RXR to
RARE-SET (Fig. 5E).

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 5.
SET does not function as a RARE. (A) Three DR-5-like
elements were tested for RA responsiveness. Synthetic oligonucleotides
with HindIII linkers were ligated in the tk-driven
luciferase reporter plasmid. (B) Only authentic RAREs in the RAR 2
promoter region confer the effect of at-RA induction. (C) DNA binding
assays. RAR-RXR heterodimers do not bind to SET. RAR-RXR bound to
labeled RARE probe is blocked by competition from the addition of
excess RARE unlabeled probes (lanes 2 to 4) but not by SET or
nonspecific (NS) probes (lanes 5 to 10). Competitor probes are
indicated above, with 2-fold excess added in lanes 2, 5, and 8; 20-fold
excess in lanes 3, 6, and 9; and 200-fold excess in lanes 4, 7, and 10. (D) TLX does not bind directly to SET. TLX bound to labeled
Krüppel probe is blocked by competition from the
addition of excess Krüppel unlabeled probes (lanes 2 to 4) but not by RARE or SET probes (lanes 5 to 10). Competitor
probes are indicated above, with 4-fold excess added in lanes 2, 5, and
8; 20-fold excess in lanes 3, 6, and 9; and 40-fold excess in lanes 4, 7, and 10. (E) TLX does not affect binding of RAR-RXR to SET- RARE.
RAR-RXR bound to labeled SET- RARE probe (lane 2) is not affected by
the addition of TLX (lane 3) or COUP-TF (lane 4). , absence of
substance; +, presence of substance.
|
|
Reconstitution of a TLX-sensitive promoter with SET and
RARE.
Similar to the situation observed with the deletion
constructs, tk-luciferase constructs containing
RARE with or without SET showed the same level of induction by at-RA in chick retina cells
(Fig. 6A). Using CV-1 cells, we could
examine the effect of TLX more clearly. SET does not function as a RARE
in CV-1 cells, and separately, neither SET nor
RARE confers an
effect in response to TLX in CV-1 cells (Fig. 6B and C). However, when
SET and
RARE are introduced together in a tk-luciferase reporter,
the at-RA induction conferred by
RARE is suppressed (Fig. 6C and D)
and expression of TLX relieves this silencing effect (Fig. 6C and D).
This effect of SET on
RARE appears position independent; similar
results were observed when the relative positions of SET and
RARE
were flipped (Fig. 7B). The ability of
TLX to restore the promoter activity of SET-
RARE to the same
level obtained with
RARE alone but no further and the inability of
TLX to directly bind either SET or
RARE suggest that SET binds
a putative repressor which can be sequestered by TLX.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 6.
Reconstitution of TLX responsiveness of the RAR 2
promoter. (A) tk-luciferase reporter constructs with synthetic
oligonucleotides depicted in Fig. 5A were transfected into chick retina
cells. SET does not have any effect in retina cells. at-RA was added to
a final concentration of 1 µM. (B to D) The same plasmids were
transfected into CV-1 cells. The introduction of SET and RARE in the
same construct restores the effect of at-RA- and TLX-dependent
transactivation. Final concentrations of at-RA are indicated.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 7.
The silencing effect of SET is independent of that of
TRE or COUP-TF-RE. (A) Sequences of mutated SET oligonucleotides are
aligned with that of the RAR 2 promoter region. TRE, COUP-TF-RE
(26), and mutated residues are boxed, underlined, and
boldfaced, respectively. (B) tk-luciferase reporter constructs with
synthetic oligonucleotides were transfected into CV-1 cells. The
silencing effect of SET is position independent. Introducing mutations
in the SET region outside TRE or COUP-TF-RE resulted in loss of the
suppression effect of SET. at-RA was added to a final concentration of
1 µM.
|
|
The silencing effect of SET is independent of that of TRE or
COUP-TF-RE.
To see if the silencing effect of SET is related to
TRE or COUP-TF-RE (26), we introduced mutations in the
region of SET overlapping with or outside those elements (Fig. 2 and
7). Mutations introduced within the overlapping region retain the
silencing effect to some extent, making interpretation difficult.
However, mutations introduced outside the overlapping region clearly
resulted in loss of the suppression effect of SET in CV-1 cells (Fig.
7), showing that elements in the SET region independent of TRE or COUP-TF-RE are indispensable for the SET silencing effect.
 |
DISCUSSION |
Evolutionary conservation of promoter region and splicing
variations of RAR
2.
Autoregulation of RAR
transcripts by
at-RA has been reported in human, mouse, and chick (11, 39, 45,
51, 54). We demonstrated that in chick the RAR
2 promoter is
responsible for this autoregulation and that RAR(s), not RXR(s),
appears to be the primary target of RA. Comparison of the chick RAR
2
promoter region with that of human and mouse revealed a strong overall conservation of structural organization, 90% in the 150-bp region surrounding the transcription start site. As for mouse, chick embryonic
retina cells also express several isoforms of RAR
mRNAs. Some of
the short uORFs (uORF2 to -5) which are hypothesized to be important
for regulating translation of the transcripts (42), as well
as the CTG start codon proposed for mouse RAR
4, are conserved in
chick (Fig. 2) (37). Together with the report that the
RAR
4 is functionally tumorigenic compared to the
2 isoform
(3), our results suggest a conserved indispensable role for
the autologous regulation and splicing variation of the RAR
gene.
Cell type-specific regulation of RAR
2 promoter by TLX.
To
date much effort has been spent to elucidate the underlying mechanism
of RAR
2 promoter activation by RA (4, 7, 9, 13, 34).
Proteins, such as E1A and COUP-TFs, have been shown to be involved in
the cell type-specific regulation of RAR
2 promoter activity
(15, 26, 46). Here we show that the orphan nuclear receptor
TLX acts as a cell type-specific regulator for RAR
2 promoter
activity. We identified a TLX-responsive element, SET, as a cell
type-specific enhancer by deletion analysis of the RAR
2 promoter.
SET acts as a cell type-specific repressor in fibroblasts, and TLX is
able to relieve this silencing effect of SET.
TLX is a member of the nuclear receptor subfamily II, which consists of
TLX, photoreceptor-specific nuclear receptor (PNR), COUP-TFs, RXRs,
hepatocyte nuclear factor 4 (HNF-4), and TR2 (6, 14, 21). We
have shown that TLX can downregulate Pax2 expression by direct binding
to its promoter region (56). COUP-TFs are also known to
repress the transcription of various genes through the COUP-TF binding
element (52), and overexpression of COUP-TFs in CV-1 cells
can repress RAR
2 promoter activity (M. Kobayashi and K. Umesono,
unpublished results).
However, the expression level of COUP-TFs has been reported to be
positively correlated with the at-RA responsiveness of the RAR
2
promoter in human cancer cell lines (26). COUP-TFs have also
been reported to act as auxiliary cofactors for HNF-4 in the activation
of the liver-specific HNF-1 promoter (23). COUP-TFs do not
directly bind to the promoter but influence promoter activity through
protein-protein interaction with HNF-4. TLX may similarly interact with
a repressor protein that binds to SET and through this interaction
relieve its repression. It is also possible that TLX and the SET
binding protein may compete for a cofactor. The intact structure of TLX
appears to be required, as overexpression of the TLX DNA binding domain
or ligand binding domain alone does not potentiate activation (data not
shown). Overexpression of the TLX DNA binding domain fused to the VP16
activation domain or engrailed repressor domain (56)
likewise did not potentiate activation (data not shown). These results
suggest that potentiation likely does not occur through the direct DNA
binding activity of TLX. COUP-TFs as well as RAR-RXR heterodimers have
been reported to enhance the activation of the estrogen receptor (ER)
promoter together with ER upon the addition of estrogen
(25). This interaction of COUP-TF and ER on the ER promoter
resembles to some extent the relationship between TLX and RAR on the
RAR
2 promoter.
Together, these observations appear to suggest that
enhancement or repression by TLX and/or COUP-TFs is highly
dependent on other factors specific to individual cell lines and/or
each promoter context. Given that we were able to reconstruct
TLX-responsive ability with SET and
RARE in the context of the tk
promoter, our finding provides an important step towards revealing some of the mechanisms behind transcriptional regulation by cell-specific factors.
To further explore the transcriptional mechanisms involving TLX, the
identification of its interacting protein is necessary. Recently, Lin
et al. found that at-RA-dependent RAR
2 transcription requires direct
binding of COUP-TFs to the element overlapping SET on the RAR
2
promoter and that COUP-TFs enhance the interaction of RAR with its
coactivator, CREB-binding protein (Fig. 2) (26). However, we
found that introducing mutations in the SET region outside the
COUP-TF-RE resulted in loss of the suppression effect of SET in CV-1
cells (Fig. 7). Therefore, it seems that the effect of SET that we
observed occurs through distinct mechanisms.
Based on analogy with other nuclear receptors, corepressor proteins,
such as SMRT and Nco-R, are good candidates for TLX-interacting protein
(reviewed in reference 30). Whether the effect of
SET and TLX might also be applicable to different REs for other RXR heterodimers is an intriguing future question too, and such studies may
reveal other aspects of TLX function.
The function of TLX and RAR
in eye development.
The
importance of TLX function in vertebrate eye development has been
implicated by gene knockout experiments in mice and the introduction of
dominant-negative and dominant-active TLX constructs in chick and
Xenopus (17, 56). These observations suggest that
TLX is involved in the signaling pathways regulating various steps in
retina and optic nerve formation and maintenance. Northern and in situ
hybridization analyses of early chick embryos confirmed its restricted
expression in fore- and midbrain and retina (57; Yu
and Kobayashi, unpublished results). In this report, we showed that the
signal transduction pathways controlled by RAR
can also be
influenced by TLX. This finding is significant because although
gene knockout and transgenic experiments in mice have suggested the
importance of RAR
in eye development (16, 19, 20, 27),
little is known about its upstream regulation.
Considering the high degree of structural and functional conservation
of TLX and the RAR
2 promoters, it is reasonable to predict a
fundamental role for TLX in the regulation of RAR in eye development.
Our findings should provide a new contribution to better
understanding of the complexity underlying the
mechanisms of eye development.
 |
ACKNOWLEDGMENTS |
We thank H. Ohizumi, K. Nozaki, H. Otani, and H. Ono for
technical assistance and members of the Yasuda Lab and Umesono Lab for
valuable discussions during the study. We also thank Jochen Buck, Lonny
R. Levin, Leonard P. Freedman, and David J. Mangelsdorf for critical
reading of the manuscript and Richard A. Heyman and Yoshiko Ishimi for
kindly providing synthetic retinoids and the MC3T3-E1 cell line, respectively.
This work was supported by Grants-in-Aid for Scientific Research from
the Ministry of Education, Science, Sports, and Culture of Japan; the
Research for the Future Program of the Japan Society for the Promotion
of Science; and the Human Frontier Science Program.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pharmacology, Joan & Sanford I. Weill Medical College of Cornell
University, 1300 York Ave., Room E-505, New York, NY 10021. Phone:
(212) 746-6453. Fax: (212) 746-6241. E-mail:
mik2007{at}med.cornell.edu.
This paper is dedicated to K. Umesono.
 |
REFERENCES |
| 1.
|
Altschul, S. F.,
W. Gish,
W. Miller,
E. W. Myers, and D. J. Lipman.
1990.
Basic local alignment search tool.
J. Mol. Biol.
215:403-410[CrossRef][Medline].
|
| 2.
|
Balkan, W.,
M. Colbert,
C. Bock, and E. Linney.
1992.
Transgenic indicator mice for studying activated retinoic acid receptors during development.
Proc. Natl. Acad. Sci. USA
89:3347-3351[Abstract/Free Full Text].
|
| 3.
|
Berard, J.,
L. Gaboury,
M. Landers,
Y. De Repentigny,
B. Houle,
R. Kothary, and W. E. Bradley.
1994.
Hyperplasia and tumours in lung, breast and other tissues in mice carrying a RAR 4-like transgene.
EMBO J.
13:5570-5580[Medline].
|
| 4.
|
Bhattacharyya, N.,
A. Dey,
S. Minucci,
A. Zimmer,
S. John,
G. Hager, and K. Ozato.
1997.
Retinoid-induced chromatin structure alterations in the retinoic acid receptor 2 promoter.
Mol. Cell. Biol.
17:6481-6490[Abstract].
|
| 5.
|
Chambon, P.
1996.
A decade of molecular biology of retinoic acid receptors.
FASEB J.
10:940-954[Abstract].
|
| 6.
|
Chen, F.,
D. J. Figueroa,
A. D. Marmorstein,
Q. Zhang,
K. Petrukhin,
C. T. Caskey, and C. P. Austin.
1999.
Retina-specific nuclear receptor: a potential regulator of cellular retinaldehyde-binding protein expressed in retinal pigment epithelium and Muller glial cells.
Proc. Natl. Acad. Sci. USA
96:15149-15154[Abstract/Free Full Text].
|
| 7.
|
Chen, J. Y.,
J. Clifford,
C. Zusi,
J. Starrett,
D. Tortolani,
J. Ostrowski,
P. R. Reczek,
P. Chambon, and H. Gronemeyer.
1996.
Two distinct actions of retinoid-receptor ligands.
Nature
382:819-822[CrossRef][Medline].
|
| 8.
|
Conlon, R. A.
1995.
Retinoic acid and pattern formation in vertebrates.
Trends Genet.
11:314-319[CrossRef][Medline].
|
| 9.
|
Davis, K. D.,
T. J. Berrodin,
J. E. Stelmach,
J. D. Winkler, and M. A. Lazar.
1994.
Endogenous retinoid X receptors can function as hormone receptors in pituitary cells.
Mol. Cell. Biol.
14:7105-7110[Abstract/Free Full Text].
|
| 10.
|
Davis, K. D., and M. A. Lazar.
1993.
Induction of retinoic acid receptor- by retinoic acid is cell specific.
Endocrinology
132:1469-1474[Abstract].
|
| 11.
|
de The, H.,
M. M. Vivanco-Ruiz,
P. Tiollais,
H. Stunnenberg, and A. Dejean.
1990.
Identification of a retinoic acid responsive element in the retinoic acid receptor gene.
Nature
343:177-180[CrossRef][Medline].
|
| 12.
|
Dey, A.,
S. Minucci, and K. Ozato.
1994.
Ligand-dependent occupancy of the retinoic acid receptor 2 promoter in vivo.
Mol. Cell. Biol.
14:8191-8201[Abstract/Free Full Text].
|
| 13.
|
Dilworth, F. J.,
C. Fromental-Ramain,
E. Remboutsika,
A. Benecke, and P. Chambon.
1999.
Ligand-dependent activation of transcription in vitro by retinoic acid receptor /retinoid X receptor heterodimers that mimics transactivation by retinoids in vivo.
Proc. Natl. Acad. Sci. USA
96:1995-2000[Abstract/Free Full Text].
|
| 14.
|
Escriva, H.,
R. Safi,
C. Hanni,
M. C. Langlois,
P. Saumitou-Laprade,
D. Stehelin,
A. Capron,
R. Pierce, and V. Laudet.
1997.
Ligand binding was acquired during evolution of nuclear receptors.
Proc. Natl. Acad. Sci. USA
94:6803-6808[Abstract/Free Full Text].
|
| 15.
|
Folkers, G. E.,
B. van der Burg, and P. T. van der Saag.
1998.
Promoter architecture, cofactors, and orphan receptors contribute to cell-specific activation of the retinoic acid receptor 2 promoter.
J. Biol. Chem.
273:32200-32212[Abstract/Free Full Text].
|
| 16.
|
Ghyselinck, N. B.,
V. Dupe,
A. Dierich,
N. Messaddeq,
J. M. Garnier,
C. Rochette-Egly,
P. Chambon, and M. Mark.
1997.
Role of the retinoic acid receptor (RAR ) during mouse development.
Int. J. Dev. Biol.
41:425-447[Medline].
|
| 17.
|
Hollemann, T.,
E. Bellefroid, and T. Pieler.
1998.
The Xenopus homologue of the Drosophila gene tailless has a function in early eye development.
Development
125:2425-2432[Abstract].
|
| 18.
|
Jackson, A.,
P. Panayiotidis, and L. Foroni.
1998.
The human homologue of the Drosophila tailless gene (TLX): characterization and mapping to a region of common deletion in human lymphoid leukemia on chromosome 6q21.
Genomics
50:34-43[CrossRef][Medline].
|
| 19.
|
Kastner, P.,
M. Mark, and P. Chambon.
1995.
Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life?
Cell
83:859-869[CrossRef][Medline].
|
| 20.
|
Kastner, P.,
M. Mark,
N. Ghyselinck,
W. Krezel,
V. Dupe,
J. M. Grondona, and P. Chambon.
1997.
Genetic evidence that the retinoid signal is transduced by heterodimeric RXR/RAR functional units during mouse development.
Development
124:313-326[Abstract].
|
| 21.
|
Kobayashi, M.,
S. Takezawa,
K. Hara,
R. T. Yu,
Y. Umesono,
K. Agata,
M. Taniwaki,
K. Yasuda, and K. Umesono.
1999.
Identification of a photoreceptor cell-specific nuclear receptor.
Proc. Natl. Acad. Sci. USA
96:4814-4819[Abstract/Free Full Text].
|
| 22.
|
Krust, A.,
P. Kastner,
M. Petkovich,
A. Zelent, and P. Chambon.
1989.
A third human retinoic acid receptor, hRAR- .
Proc. Natl. Acad. Sci. USA
86:5310-5314[Abstract/Free Full Text].
|
| 23.
|
Ktistaki, E., and I. Talianidis.
1997.
Chicken ovalbumin upstream promoter transcription factors act as auxiliary cofactors for hepatocyte nuclear factor 4 and enhance hepatic gene expression.
Mol. Cell. Biol.
17:2790-2797[Abstract].
|
| 24.
|
Ladias, J. A., and S. K. Karathanasis.
1991.
Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily.
Science
251:561-565[Abstract/Free Full Text].
|
| 25.
|
Lazennec, G.,
L. Kern,
Y. Valotaire, and G. Salbert.
1997.
The nuclear orphan receptors COUP-TF and ARP-1 positively regulate the trout estrogen receptor gene through enhancing autoregulation.
Mol. Cell. Biol.
17:5053-5066[Abstract].
|
| 26.
|
Lin, B.,
G. Q. Chen,
D. Xiao,
S. K. Kolluri,
X. Cao,
H. Su, and X. K. Zhang.
2000.
Orphan receptor COUP-TF is required for induction of retinoic acid receptor , growth inhibition, and apoptosis by retinoic acid in cancer cells.
Mol. Cell. Biol.
20:957-970[Abstract/Free Full Text].
|
| 27.
|
Luo, J.,
H. M. Sucov,
J. A. Bader,
R. M. Evans, and V. Giguere.
1996.
Compound mutants for retinoic acid receptor (RAR) beta and RAR alpha 1 reveal developmental functions for multiple RAR beta isoforms.
Mech. Dev.
55:33-44[CrossRef][Medline].
|
| 28.
|
Mangelsdorf, D. J., and R. M. Evans.
1995.
The RXR heterodimers and orphan receptors.
Cell
83:841-850[CrossRef][Medline].
|
| 29.
|
Mangelsdorf, D. J.,
C. Thummel,
M. Beato,
P. Herrlich,
G. Schütz,
K. Umesono,
B. Blumberg,
P. Kastner,
M. Mark,
P. Chambon, and R. M. Evans.
1995.
The nuclear receptor superfamily: the second decade.
Cell
83:835-839[CrossRef][Medline].
|
| 30.
|
McKenna, N. J.,
R. B. Lanz, and B. W. O'Malley.
1999.
Nuclear receptor coregulators: cellular and molecular biology.
Endocr. Rev.
20:321-344[Abstract/Free Full Text].
|
| 31.
|
Mendelsohn, C.,
E. Ruberte,
M. LeMeur,
G. Morriss-Kay, and P. Chambon.
1991.
Developmental analysis of the retinoic acid-inducible RAR- 2 promoter in transgenic animals.
Development
113:723-734[Abstract].
|
| 32.
|
Michaille, J. J.,
S. Blanchet,
B. Kanzler,
J. M. Garnier, and D. Dhouailly.
1994.
Characterization of cDNAs encoding the chick retinoic acid receptor 2 and preferential distribution of retinoic acid receptor transcripts during chick skin development.
Dev. Dyn.
201:334-343[Medline].
|
| 33.
|
Michaille, J. J.,
B. Kanzler,
S. Blanchet,
J. M. Garnier, and D. Dhouailly.
1995.
Characterization of cDNAs encoding two chick retinoic acid receptor isoforms and distribution of retinoic acid receptor , and transcripts during chick skin development.
Int. J. Dev. Biol.
39:587-596[Medline].
|
| 34.
|
Minucci, S.,
V. Horn,
N. Bhattacharyya,
V. Russanova,
V. V. Ogryzko,
L. Gabriele,
B. H. Howard, and K. Ozato.
1997.
A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells.
Proc. Natl. Acad. Sci. USA
94:11295-11300[Abstract/Free Full Text].
|
| 35.
|
Monaghan, A. P.,
D. Bock,
P. Gass,
A. Schwäger,
D. P. Wolfer,
H.-P. Lipp, and G. Schütz.
1997.
Defective limbic system in mice lacking the tailless gene.
Nature
390:515-517[CrossRef][Medline].
|
| 36.
|
Monaghan, A. P.,
E. Grau,
D. Bock, and G. Schutz.
1995.
The mouse homolog of the orphan nuclear receptor tailless is expressed in the developing forebrain.
Development
121:839-853[Abstract].
|
| 37.
|
Nagpal, S.,
A. Zelent, and P. Chambon.
1992.
RAR- 4, a retinoic acid receptor isoform, is generated from RAR- 2 by alternative splicing and usage of a CUG initiator codon.
Proc. Natl. Acad. Sci. USA
89:2718-2722[Abstract/Free Full Text].
|
| 38.
|
Nohno, T.,
K. Muto,
S. Noji,
T. Saito, and S. Taniguchi.
1991.
Isoforms of retinoic acid receptor expressed in the chicken embryo.
Biochim. Biophys. Acta
1089:273-275[Medline].
|
| 39.
|
Noji, S.,
T. Nohno,
E. Koyama,
K. Muto,
K. Ohyama,
Y. Aoki,
K. Tamura,
K. Ohsugi,
H. Ide,
S. Taniguchi, and T. Saito.
1991.
Retinoic acid induces polarizing activity but is unlikely to be a morphogen in the chick limb bud.
Nature
350:83-86[CrossRef][Medline].
|
| 40.
|
Okada, T. S.,
K. Yasuda,
M. Araki, and G. Eguchi.
1979.
Possible demonstration of multipotential nature of embryonic neural retina by clonal cell culture.
Dev. Biol.
68:600-617[CrossRef][Medline].
|
| 41.
|
Reynolds, K.,
E. Mezey, and A. Zimmer.
1991.
Activity of the -retinoic acid receptor promoter in transgenic mice.
Mech. Dev.
36:15-29[CrossRef][Medline].
|
| 42.
|
Reynolds, K.,
A. M. Zimmer, and A. Zimmer.
1996.
Regulation of RAR 2 mRNA expression: evidence for an inhibitory peptide encoded in the 5'-untranslated region.
J. Cell. Biol.
134:827-835[Abstract/Free Full Text].
|
| 43.
|
Rossant, J.,
R. Zirngibl,
D. Cado,
M. Shago, and V. Giguere.
1991.
Expression of a retinoic acid response element-hsplacZ transgene defines specific domains of transcriptional activity during mouse embryogenesis.
Genes Dev.
5:1333-1344[Abstract/Free Full Text].
|
| 44.
|
Rowe, A.,
J. M. Richman, and P. M. Brickell.
1992.
Development of the spatial pattern of retinoic acid receptor- transcripts in embryonic chick facial primordia.
Development
114:805-813[Abstract].
|
| 45.
|
Rowe, A.,
J. M. Richman, and P. M. Brickell.
1991.
Retinoic acid treatment alters the distribution of retinoic acid receptor- transcripts in the embryonic chick face.
Development
111:1007-1016[Abstract/Free Full Text].
|
| 46.
|
Sanguedolce, M. V.,
B. P. Leblanc,
J. L. Betz, and H. G. Stunnenberg.
1997.
The promoter context is a decisive factor in establishing selective responsiveness to nuclear class II receptors.
EMBO J.
16:2861-2873[CrossRef][Medline].
|
| 47.
|
Shen, S.,
F. A. E. Kruyt,
J. D. Hertog, and P. T. van der Saag.
1991.
Mouse and human retinoic acid receptor 2 promoters: sequence comparison and localization of retinoic acid responsiveness.
DNA Sequence
2:111-119[Medline].
|
| 48.
|
Smith, S. M.
1994.
Retinoic acid receptor isoform 2 is an early marker for alimentary tract and central nervous system positional specification in the chicken.
Dev. Dyn.
200:14-25[Medline].
|
| 49.
|
Smith, S. M.,
E. D. Dickman,
S. C. Power, and J. Lancman.
1998.
Retinoids and their receptors in vertebrate embryogenesis.
J. Nutr.
128:467S-470S.
|
| 50.
|
Smith, S. M., and G. Eichele.
1991.
Temporal and regional differences in the expression pattern of distinct retinoic acid receptor- transcripts in the chick embryo.
Development
111:245-252[Abstract].
|
| 51.
|
Sucov, H. M.,
K. K. Murakami, and R. M. Evans.
1990.
Characterization of an autoregulated response element in the mouse retinoic acid receptor type gene.
Proc. Natl. Acad. Sci. USA
87:5392-5396[Abstract/Free Full Text].
|
| 52.
|
Tsai, S. Y., and M.-J. Tsai.
1997.
Chick ovalbumin upstream promoter-transcription factors (COUP-TFs): coming of age.
Endocr. Rev.
18:229-240[Abstract/Free Full Text].
|
| 53.
|
Umesono, K.,
K. K. Murakami,
C. C. Thompson, and R. M. Evans.
1991.
Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors.
Cell
65:1255-1266[CrossRef][Medline].
|
| 54.
|
Wanek, N.,
D. M. Gardiner,
K. Muneoka, and S. V. Bryant.
1991.
Conversion by retinoic acid of anterior cells into ZPA cells in the chick wing bud.
Nature
350:81-83[CrossRef][Medline].
|
| 55.
|
Yao, T. P.,
B. M. Forman,
Z. Jiang,
L. Cherbas,
J. D. Chen,
M. McKeown,
P. Cherbas, and R. M. Evans.
1993.
Functional ecdysone receptor is the product of EcR and Ultraspiracle genes.
Nature
366:476-479[CrossRef][Medline].
|
| 56.
|
Yu, R. T.,
M. Y. Chiang,
T. Tanabe,
M. Kobayashi,
K. Yasuda,
R. M. Evans, and K. Umesono.
2000.
The orphan nuclear receptor Tlx regulates Pax2 and is essential for vision.
Proc. Natl. Acad. Sci. USA
97:2621-2625[Abstract/Free Full Text].
|
| 57.
|
Yu, R. T.,
M. McKeown,
R. M. Evans, and K. Umesono.
1994.
Relationship between Drosophila gap gene tailless and a vertebrate nuclear receptor Tlx.
Nature
370:375-379[CrossRef][Medline].
|
| 58.
|
Zelent, A.,
A. Krust,
M. Petkovich,
P. Kastner, and P. Chambon.
1989.
Cloning of murine and retinoic acid receptors and a novel receptor predominantly expressed in skin.
Nature
339:714-717[CrossRef][Medline].
|
| 59.
|
Zelent, A.,
C. Mendelsohn,
P. Kastner,
A. Krust,
J. M. Garnier,
F. Ruffenach,
P. Leroy, and P. Chambon.
1991.
Differentially expressed isoforms of the mouse retinoic acid receptor are generated by usage of two promoters and alternative splicing.
EMBO J.
10:71-81[Medline].
|
Molecular and Cellular Biology, December 2000, p. 8731-8739, Vol. 20, No. 23
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Benoit, G., Cooney, A., Giguere, V., Ingraham, H., Lazar, M., Muscat, G., Perlmann, T., Renaud, J.-P., Schwabe, J., Sladek, F., Tsai, M.-J., Laudet, V.
(2006). International Union of Pharmacology. LXVI. Orphan Nuclear Receptors. Pharmacol. Rev.
58: 798-836
[Abstract]
[Full Text]
-
Abrahams, B. S., Kwok, M. C. H., Trinh, E., Budaghzadeh, S., Hossain, S. M., Simpson, E. M.
(2005). Pathological Aggression in "Fierce" Mice Corrected by Human Nuclear Receptor 2E1. J. Neurosci.
25: 6263-6270
[Abstract]
[Full Text]